Gregory Licholai
Chief Tech/Sci/R&D Officer at ICON PUBLIC LIMITED COMPANY
Profile
Founder of Immunome, Inc., Gregory P. Licholai currently is Chief Medical & Innovation Officer at ICON plc and President of Elpidera LLC. Dr. Licholai is also on the board of Sollis Therapeutics, Inc. He previously occupied the position of President & Chief Scientific Officer at Castle Creek Pharmaceuticals LLC, Vice President-Medical Affairs at Amicus Therapeutics, Inc., Director-Ventures & Business Associates at Medtronic Neurological and Director at Immunome, Inc. Gregory P. Licholai received an undergraduate degree from Boston College, a doctorate from Yale University and an MBA from Harvard University.
Gregory Licholai active positions
| Companies | Position | Start |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| Elpidera LLC | President | - |
Former positions of Gregory Licholai
| Companies | Position | End |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | President | 2018-01-31 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-10-01 |
| Medtronic Neurological | Corporate Officer/Principal | 2002-10-31 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Gregory Licholai
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Yale School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Medtronic Neurological | |
| Elpidera LLC | |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Gregory Licholai
